Jetstream™

Atherectomy System

Long Term Outcomes with Jetstream Atherectomy System with or without Drug Coated Balloons in Treating Femoropopliteal Arteries: A Single Center Experience

The JET-SCE¹

Objective

The JET-SCE observed the long-term outcomes in treating femoropopliteal arteries with drug coated balloons versus plain old balloon angioplasty post Jetstream™ Atherectomy.

Key Resources

Indications, Safety and Warnings

Sign-Up for
Atherectomy Updates

Request a Sales Rep

Submit Your Questions

Patient and Lesion Characteristics

Patient Characteristics

81 patients
49.4% male
68.3 average age
53.1 % diabetic

Lesion Characteristics

25.9% CTOs
14.9 cm average lesion length in PTA cohort
12.0 cm average lesion length in DCB cohort

The JET-SCE included patients with de novo or restenotic femoropopliteal lesions whose symptoms were classified as Rutherford Category I-V

Results

At 12-months results demonstrated 95.2% freedom from TLR with Jetstream + DCB

Jetstream Device and Procedural Success

87% Device Success (<50% stenosis post Jetstream alone)
94% Procedural Success (<30% residual final treatment)

Patient Procedure Details and Outcomes

12-months: Jetstream + DCB 95.2% freedom from TLR
12-months: Jetstream + PTA 69.8% freedom from TLR
18-months: Jetstream + DCB 91.1% freedom from TLR
18-months: Jetstream + PTA 63.7% freedom from TLR
28 patients received adjunctive DCB
53 patients received adjunctive PTA

Minimal Luminal Diameter

Baseline: 1.5 mm ± 1.4 mm
Post Jetstream: 3.1 mm ± 1.2 mm
Post Final Treatment: 4.2 mm ± 0.9 mm

Top